Operation Warp Speed
-
{
- All
- News
-
'Operation Warp Speed' Was One Of Trump's Big Achievements. Then Came RFK Jr
President Donald Trump launched Operation Warp Speed in the throes of the COVID-19 pandemic, an effort he has credited with saving tens of millions of lives.
-
Biden Asked Not To Accept India-Led Proposal At World Trade Body On Covid Vaccine Patents
Four top Republicans Senator on Friday urged US President Joe Biden not to accept a proposal by India and S Africa to the World Trade Organisation to waive anti-Covid vaccine patents to boost its supply.
-
Moderna, Pfizer Start Decisive Covid Vaccine Trials, Eye Year-End Launches
Moderna Inc and Pfizer Inc launched two 30,000-subject trials of COVID-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year, the companies said on Monday.
-
US Pharma Firm Moderna's COVID-19 Vaccine Candidate Enters Late-Stage Trial
Moderna said on Monday it has started a US government-backed late-stage trial to assess its COVID-19 vaccine candidate in about 30,000 adults who do not have the respiratory illness caused by the new coronavirus.
-
'Operation Warp Speed' Was One Of Trump's Big Achievements. Then Came RFK Jr
President Donald Trump launched Operation Warp Speed in the throes of the COVID-19 pandemic, an effort he has credited with saving tens of millions of lives.
-
Biden Asked Not To Accept India-Led Proposal At World Trade Body On Covid Vaccine Patents
Four top Republicans Senator on Friday urged US President Joe Biden not to accept a proposal by India and S Africa to the World Trade Organisation to waive anti-Covid vaccine patents to boost its supply.
-
Moderna, Pfizer Start Decisive Covid Vaccine Trials, Eye Year-End Launches
Moderna Inc and Pfizer Inc launched two 30,000-subject trials of COVID-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year, the companies said on Monday.
-
US Pharma Firm Moderna's COVID-19 Vaccine Candidate Enters Late-Stage Trial
Moderna said on Monday it has started a US government-backed late-stage trial to assess its COVID-19 vaccine candidate in about 30,000 adults who do not have the respiratory illness caused by the new coronavirus.
